Tiny drops, big questions: new study eyes steroid safety in preterm infants
NCT ID NCT05387941
First seen May 02, 2026 · Last updated May 23, 2026 · Updated 5 times
Summary
This study looked at how steroid eye drops are absorbed and broken down in premature babies who have retinopathy of prematurity, an eye condition that can lead to blindness. Eleven infants born before 30 weeks of pregnancy took part. Researchers took blood and saliva samples to measure the drug levels and checked for side effects like high blood pressure or slowed growth. The goal was to gather information to make the treatment safer and more effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINOPATHY OF PREMATURITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sahlgrenska University Hospital
Gothenburg, Västra Götaland County, 41685, Sweden
-
Skåne University Hospital
Lund, Skåne County, 22185, Sweden
Conditions
Explore the condition pages connected to this study.